Novavax (NVAX) Commences Enrollment in A/H5N1 Vaccine Candidate Phase I

Go back to Novavax (NVAX) Commences Enrollment in A/H5N1 Vaccine Candidate Phase I
Novavax, Inc. (NASDAQ: NVAX) Delayed: 9.26 +0.21 (2.32%)
Previous Close $9.05    52 Week High $9.23 
Open $9.18    52 Week Low $1.16 
Day High $9.34    P/E N/A 
Day Low $8.89    EPS $-0.30 
Volume 4,211,667